RDNT
RadNet, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$73.71
−1.22%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.3B | 2.0B | 1.8B | 1.6B | 1.4B |
| Cost of Revenue | 2.0B | 1.9B | 1.6B | 1.4B | 1.3B |
| Gross Profit | 220.1M | 90.8M | 249.1M | 221.4M | 165.7M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 129.3M | — | 144.5M | 122.7M | 119.4M |
| Total Operating Expenses | 129.3M | — | 144.5M | 122.7M | 119.4M |
| Cost and Expenses | 2.2B | 1.9B | 1.7B | 1.5B | 1.4B |
| Operating Income (EBIT) | 90.8M | 90.8M | 104.6M | 98.7M | 46.4M |
| Non-Operating | |||||
| Interest Income | 5.1M | — | — | — | — |
| Interest Expense | 71.3M | 69.9M | 79.8M | 64.5M | 50.8M |
| Net Interest Income | (66.2M) | (69.9M) | (79.8M) | (64.5M) | (50.8M) |
| Other Non-Op Income/Expense | (55.9M) | (58.9M) | (59.8M) | (59.9M) | (3.4M) |
| Non-Operating Income (excl Interest) | (15.4M) | (11.0M) | (20.1M) | (4.6M) | (47.4M) |
| EBT (Pre-Tax Income) | 35.0M | 31.9M | 44.9M | 38.8M | 43.0M |
| Income Tax Expense | 15.7M | 14.9M | 6.0M | 8.5M | 9.4M |
| Bottom Line | |||||
| Net Income | (21.1M) | (18.7M) | 2.8M | 3.0M | 10.7M |
| Earnings from Cont. Ops | 19.3M | 17.0M | 38.8M | 30.3M | 33.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (21.1M) | (18.7M) | 2.8M | 3.0M | 10.7M |
| Per Share | |||||
| Basic EPS | ($0.27) | ($0.25) | $0.04 | $0.05 | $0.19 |
| Diluted EPS | ($0.27) | ($0.25) | $0.04 | $0.05 | $0.17 |
| Revenue Per Share | $29.17 | $27.13 | $25.05 | $25.43 | $25.40 |
| Shares | |||||
| Basic Shares Outstanding | 77.8M | 75.2M | 73.0M | 63.6M | 56.3M |
| Diluted Shares Outstanding | 78.7M | 75.2M | 74.8M | 64.7M | 57.3M |
| Profitability Metrics | |||||
| EBITDA | 337.3M | 253.9M | 262.5M | 292.8M | 278.5M |
| D&A | 231.0M | 152.1M | 137.8M | 189.5M | 184.7M |
| EBIT | 106.3M | 101.8M | 124.7M | 103.3M | 93.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026